Patent: 5,557,032
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,557,032
Title: | Knockout mice |
Abstract: | Mice lacking expression of CD28 or particular CD45 isoforms in certain cells of the immune system are provided. Also provided are methods of using these mice. |
Inventor(s): | Mak; Tak W. (Toronto, CA) |
Assignee: | Ontario Cancer Institute (Toronto, CA) Thompson; Craig Bernie (Chicago, IL) |
Application Number: | 08/451,691 |
Patent Claims: | see list of patent claims |
Details for Patent 5,557,032
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | See Plans and Pricing | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | See Plans and Pricing | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | See Plans and Pricing | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |